Truist Financial Increases Intuitive Surgical (NASDAQ:ISRG) Price Target to $347.00

Intuitive Surgical (NASDAQ:ISRG – Get Rating) had its target price hoisted by Truist Financial from $325.00 to $347.00 in a report released on Thursday, The Fly reports. Truist Financial’s price objective would indicate a potential upside of 10.65% from the company’s current price.

A number of other equities research analysts have also weighed in on ISRG. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $285.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, April 19th. Raymond James upped their target price on Intuitive Surgical from $270.00 to $323.00 and gave the stock an “outperform” rating in a report on Wednesday, April 19th. Citigroup raised their target price on Intuitive Surgical from $305.00 to $317.00 and gave the company a “buy” rating in a research note on Wednesday, April 19th. UBS Group assumed coverage on Intuitive Surgical in a research note on Tuesday, March 28th. They issued a “neutral” rating and a $278.00 price target on the stock. Finally, Sanford C. Bernstein raised their price objective on Intuitive Surgical from $325.00 to $350.00 and gave the company an “outperform” rating in a research report on Thursday, April 20th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $300.50.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $313.61 on Thursday. Intuitive Surgical has a 1 year low of $180.07 and a 1 year high of $315.20. The stock has a market capitalization of $109.89 billion, a PE ratio of 85.69, a PEG ratio of 5.51 and a beta of 1.31. The business’s 50-day moving average is $275.30 and its 200 day moving average is $261.49.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its quarterly earnings data on Tuesday, April 18th. The medical equipment provider reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.03. The business had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Intuitive Surgical had a return on equity of 11.39% and a net margin of 20.40%. The business’s revenue was up 14.3% on a year-over-year basis. During the same quarter last year, the business posted $1.00 EPS. As a group, equities research analysts anticipate that Intuitive Surgical will post 4.3 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Mark J. Rubash sold 1,683 shares of the business’s stock in a transaction on Friday, April 21st. The shares were sold at an average price of $297.92, for a total transaction of $501,399.36. Following the completion of the sale, the director now directly owns 15,000 shares in the company, valued at approximately $4,468,800. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, Director Mark J. Rubash sold 1,683 shares of the business’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $297.92, for a total transaction of $501,399.36. Following the completion of the sale, the director now directly owns 15,000 shares in the company, valued at $4,468,800. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Fredrik Widman sold 630 shares of the firm’s stock in a transaction on Friday, April 21st. The stock was sold at an average price of $297.87, for a total value of $187,658.10. Following the completion of the transaction, the vice president now directly owns 2,233 shares in the company, valued at $665,143.71. The disclosure for this sale can be found here. Insiders have sold a total of 61,276 shares of company stock worth $18,253,410 over the last quarter. Company insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently modified their holdings of ISRG. MADDEN SECURITIES Corp purchased a new stake in Intuitive Surgical during the 4th quarter valued at approximately $26,000. HHM Wealth Advisors LLC increased its holdings in Intuitive Surgical by 1,314.3% in the 1st quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 92 shares during the last quarter. Paragon Wealth Strategies LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth $27,000. Bogart Wealth LLC boosted its holdings in shares of Intuitive Surgical by 721.4% during the 1st quarter. Bogart Wealth LLC now owns 115 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 101 shares during the last quarter. Finally, Barrett & Company Inc. bought a new position in shares of Intuitive Surgical during the 1st quarter valued at about $30,000. 81.96% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.